Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synthetic Angiotensin II in Pediatric Patients With Refractory Hypotension
NCT07212686Phase 4Enrolling by invitation
- Sponsor
- Northwell Health
- Start
- Oct 2025
- Primary completion
- Jun 2030
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Angiotensin II in vasodilatory shock, sponsored by Northwell Health. Started Oct 2025; status: enrolling by invitation.
02
Drugs
Angiotensin II
03
Conditions
vasodilatory shock
Beyond the preview
Go deeper on NCT07212686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07212686.